Recell
Payments companies reported to CMS as associated with Recell. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Recell, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Recell
These are the largest totals companies reported as associated with Recell. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jeffrey Carter | New Orleans, LA | Trauma Surgery | $138,089.69 |
| Carmen Flores | Las Vegas, NV | Surgical Critical Care | $75,902.50 |
| Ian Valerio | Columbus, OH | Plastic Surgery | $67,482.91 |
| William Hickerson | Memphis, TN | Plastic and Reconstructive Surgery | $55,856.48 |
| James Holmes | Winston Salem, NC | Trauma Surgery | $55,206.91 |
| Steven Kahn | Charleston, SC | Surgery | $53,847.26 |
| Rajiv Sood | Hoffman Estates, IL | Internal Medicine | $52,537.35 |
| Derek Bell | Rochester, NY | Plastic Surgery | $41,292.54 |
| Charles Hultman | Raleigh, NC | Plastic and Reconstructive Surgery | $39,133.39 |
| Anjay Khandelwal | Akron, OH | Surgery | $38,548.38 |
Prescribed Recell?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.